[[6, 43, [[6, 939, "Table 2. SAR Summary of C-3'-6-Alkyne Analogues (29-30)a,b,"]]], [67, 92, [[1007, 1054, "NH2"]]], [170, 186, [[705, 737, "HO"]]], [229, 241, [[808, 824, "R"]]], [257, 288, [[818, 870, "HO`"], [915, 965, "OH"]]], [325, 409, [[284, 379, "Compd"], [447, 488, "R1"], [627, 671, "R2"], [802, 973, "Human CD73 IC5oa (nM)"], [1034, 1245, "Human plasma CD73 IC50b (nM)"], [1318, 1481, "Rat iv CLc (mL/min/kg)"]]], [478, 513, [[312, 351, "20"], [447, 490, "Bn"], [864, 911, "1.7"], [1116, 1163, "5.6"], [1384, 1422, "13"]]], [597, 631, [[312, 351, "29"], [445, 490, "Bn"], [588, 709, "Me-="], [864, 911, "1.0"], [1118, 1165, "1.6"], [1378, 1426, "9.9"]]], [715, 750, [[312, 353, "30"], [447, 490, "Bn"], [864, 911, "0.5"], [1118, 1163, "1.5"], [1382, 1422, "54"]]], [834, 856, [[8, 1781, "The inhibitory actiyity was evaluated against recombinant human CD73 (0.0S nM) using a malachite green assay. A lower CD73 enzym"]]], [866, 893, [[6, 1785, "concentration level was applied to accurately assess the inhibitory activity of the more potent new analogues. Inhibition of CD73 in plasma wa"]]], [903, 922, [[4, 1781, "measured using LC/MS to assess the conversion of ISN.-AMP into ISN--ADO. cRat clearance was determined from iv dosing at a 1 mg/kg dose"]]]]